基于我的搜索结果，现在让我整理出关于STAT6在不同类型肿瘤中表达特征、功能作用及其作为治疗靶点的相关文献：

----
id: "delgado-ramirez2020_stat6_colon"
title: "Signal transducer and activator of transcription 6 as a target in colon cancer"
authors: ["Y. Delgado-Ramirez"]
year: 2020
journal: "PMC"
doi: "10.3390/cancers12051245"
citation_key: "delgado-ramirez2020"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC7285805/"
content: |
  结直肠癌患者在结肠上皮中表现出高STAT6活性，STAT6表达与较低的生存率、淋巴结转移相关。使用STAT6特异性抑制剂AS1517499可减少肿瘤生长和疾病进展的迹象。STAT6抑制可能作为结肠癌的治疗靶点。

----
id: "binnemars-postma2018_stat6_tam"
title: "Targeting the Stat6 pathway in tumor-associated macrophages"
authors: ["K. Binnemars-Postma"]
year: 2018
journal: "FASEB Journal"
doi: "10.1096/fj.201700629R"
citation_key: "binnemars-postma2018"
url: "https://faseb.onlinelibrary.wiley.com/doi/full/10.1096/fj.201700629R"
content: |
  抑制TAMs中的Stat6通路是通过抑制TAM诱导的促肿瘤和免疫抑制功能来减弱肿瘤生长和转移的重要治疗方法。STAT6通路在肿瘤相关巨噬细胞中发挥关键作用。

----
id: "wang2010_stat6_eZH2_crc"
title: "EZH2 and STAT6 expression profiles are correlated with colorectal cancer progression and prognosis"
authors: ["C.G. Wang"]
year: 2010
journal: "PMC"
doi: "10.1186/1471-2407-10-188"
citation_key: "wang2010"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC2874149/"
content: |
  EZH2和STAT6表达在区分结直肠癌临床分期和预测患者预后方面具有显著价值。STAT6表达与结直肠癌进展密切相关。

----
id: "park2019_stat6_glioblastoma"
title: "Epigenetic downregulation of STAT6 increases HIF-1α expression in glioblastoma"
authors: ["S.J. Park"]
year: 2019
journal: "PMC"
doi: "10.18632/oncotarget.27090"
citation_key: "park2019"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC6747735/"
content: |
  STAT6在恶性胶质母细胞瘤中表观遗传学沉默，这有助于癌细胞在缺氧环境中的存活。STAT6可能在某些情况下发挥肿瘤抑制因子的作用。

----
id: "mentz2022_stat6_fl"
title: "PARP14 is a novel target in STAT6 mutant follicular lymphoma"
authors: ["M. Mentz"]
year: 2022
journal: "Nature Leukemia"
doi: "10.1038/s41375-022-01641-x"
citation_key: "mentz2022"
url: "https://www.nature.com/articles/s41375-022-01641-x"
content: |
  IL-4与其受体结合在淋巴瘤细胞上招募JAK1/3并通过Y641磷酸化激活STAT6。这促进了STAT6突变滤泡性淋巴瘤的发展。PARP14被确定为STAT6突变滤泡性淋巴瘤的新靶点。

----
id: "kamerkar2022_exosome_stat6"
title: "Exosome-mediated genetic reprogramming of tumor-associated macrophages via STAT6 targeting"
authors: ["S. Kamerkar"]
year: 2022
journal: "Science Advances"
doi: "10.1126/sciadv.abj7002"
citation_key: "kamerkar2022"
url: "https://www.science.org/doi/10.1126/sciadv.abj7002"
content: |
  exoASO-STAT6是一种新型的一流疗法，可有效重编程TAMs，并显著增强抗肿瘤免疫反应。基于基因表达模式，STAT6特征富集的肿瘤存在于免疫细胞丰富的肿瘤和巨噬细胞中。

----
id: "verhoeven2020_stat6_review"
title: "The potential and controversy of targeting STAT family members in cancer therapy"
authors: ["Y. Verhoeven"]
year: 2020
journal: "Seminars in Cancer Biology"
doi: "10.1016/j.semcancer.2019.03.002"
citation_key: "verhoeven2020"
url: "https://www.sciencedirect.com/science/article/pii/S1044579X19300513"
content: |
  最近的抑制研究表明，靶向STAT6信号传导可减少胃癌、乳腺癌、Lewis肺癌等多种实体瘤的肿瘤生长和/或转移。STAT6在癌症中显示出双重作用，既可作为致癌因子也可作为肿瘤抑制因子，具体取决于细胞环境。

----
id: "zhou2022_pan_cancer_stat6"
title: "A pan-cancer analysis of the expression of STAT family members"
authors: ["M. Zhou"]
year: 2022
journal: "Frontiers in Oncology"
doi: "10.3389/fonc.2022.925537"
citation_key: "zhou2022"
url: "https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.925537/full"
content: |
  最近的研究表明，STAT6信号传导可减少胃肠道、乳腺、肺等实体瘤的癌性生长和/或转移。STAT6在不同癌症类型中显示出不同的表达模式和预后意义。

----
id: "li2024_stat6_asos"
title: "STAT6-targeting antisense oligonucleotides against solid tumors"
authors: ["Y. Li"]
year: 2024
journal: "Molecular Therapy - Nucleic Acids"
doi: "10.1016/j.omtn.2024.102141"
citation_key: "li2024"
url: "https://www.sciencedirect.com/science/article/pii/S2162253124000416"
content: |
  本研究评估了靶向STAT6 3'UTR的单链DNA反义寡核苷酸，目的是下调所有NAB2-STAT6融合转录本的表达。STAT6靶向治疗在实体瘤中显示出治疗潜力。

----
id: "benoit2024_stat6_dlbcl"
title: "STAT6 mutations enriched at diffuse large B-cell lymphoma transformation"
authors: ["A. Benoit"]
year: 2024
journal: "PMC"
doi: "10.1182/blood.2023023557"
citation_key: "benoit2024"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC10920476/"
content: |
  STAT6阳性肿瘤可能在T细胞中富集。STAT6突变在弥漫性大B细胞淋巴瘤转化中富集，表明其在淋巴瘤进展中的重要作用。

----
id: "shi2023_traf3_stat6_macrophage"
title: "TRAF3/STAT6 axis regulates macrophage polarization and cancer therapy"
authors: ["J.H. Shi"]
year: 2023
journal: "PMC"
doi: "10.1038/s41419-023-05645-4"
citation_key: "shi2023"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC10406838/"
content: |
  将肿瘤相关巨噬细胞从M2表型转换为M1表型被认为是癌症治疗的有效策略。TRAF3/STAT6轴在调节巨噬细胞极化和癌症治疗中发挥关键作用。

----
id: "discala2020_stat6_breast"
title: "Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in breast cancer"
authors: ["M. DiScala"]
year: 2020
journal: "PLOS ONE"
doi: "10.1371/journal.pone.0234146"
citation_key: "discala2020"
url: "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0234146"
content: |
  大约3%的乳腺癌中STAT6表达缺失，但在曲妥珠单抗耐药背景下研究较少。STAT6缺失导致乳腺癌中的锚定非依赖性生长和曲妥珠单抗耐药。

----
id: "hill2025_nab2_stat6_sft"
title: "NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in solitary fibrous tumors"
authors: ["C.M. Hill"]
year: 2025
journal: "eLife"
doi: "10.7554/eLife.98072"
citation_key: "hill2025"
url: "https://elifesciences.org/reviewed-preprints/98072"
content: |
  致癌性NAB2-STAT6融合可能因此在孤立性纤维瘤中增强其自身表达。NAB2-STAT6在SFTs发病机制中的确切作用仍不清楚，可能根据细胞环境作为癌基因或肿瘤抑制因子发挥作用。

----
id: "wang2024_stat_transcription_factors"
title: "Oncogenic STAT Transcription Factors as Targets for Cancer Therapy"
authors: ["W. Wang"]
year: 2024
journal: "PMC"
doi: "10.3390/cancers16081481"
citation_key: "wang2024"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC11011165/"
content: |
  调节基因表达的蛋白质，称为转录因子，在癌细胞中异常调节，特别是一组称为STATs的蛋白质。STAT转录因子作为癌症治疗靶点具有重要潜力。

----
id: "liu2024_stat6_linc01637_um"
title: "STAT6/LINC01637 axis regulates tumor growth via autophagy in uveal melanoma"
authors: ["B. Liu"]
year: 2024
journal: "PMC"
doi: "10.1186/s12943-024-02027-6"
citation_key: "liu2024"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC11445459/"
content: |
  STAT6/LINC01637轴通过自噬促进葡萄膜黑色素瘤进展，并可能作为UM的潜在治疗靶点。STAT6在不同类型癌症中显示出多种功能作用。